Shumin Ouyang
Overview
Explore the profile of Shumin Ouyang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
222
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ouyang S, Li H, Lou L, Huang Q, Zhang Z, Mo J, et al.
Redox Biol
. 2022 Apr;
52:102317.
PMID: 35483272
Chemotherapy is still one of the principal treatments for gastric cancer, but the clinical application of 5-FU is limited by drug resistance. Here, we demonstrate that ferroptosis triggered by STAT3...
12.
Han L, Liang S, Mu W, Zhang Z, Wang L, Ouyang S, et al.
Asian J Pharm Sci
. 2022 Mar;
17(1):129-138.
PMID: 35261649
Nanomedicine has made great progress in the targeted therapy of cancer. Here, we established a novel drug-mate strategy by studying the formulation of nanodrugs at the molecular level. In the...
13.
Huang Q, Zhong Y, Li B, Ouyang S, Deng L, Mo J, et al.
Eur J Med Chem
. 2021 May;
221:113525.
PMID: 34000483
STAT3 has been validated as an attractive anticancer target due to its important roles in cancer initiation and progression. However, discovery of potent and selective STAT3 small-molecule inhibitors with druglike...
14.
Zheng Q, Dong H, Mo J, Zhang Y, Huang J, Ouyang S, et al.
Theranostics
. 2021 Jan;
11(2):824-840.
PMID: 33391507
Constitutive activation of signal transducer and activator of transcription 3 (STAT3) is a common feature in human non-small cell lung cancer (NSCLC). STAT3 plays an important role in cancer progression...